NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to implementation of P.L. 115-97 Tax Cuts and Jobs Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ELIZABETH SEMENIUK | — |
Defense DEF
H.R. 4710 Pharmaceutical Independence Long-Term Readiness Reform Act and related "Buy American" procurement issues in Fiscal Year 2021 National Defense Authorization Act (NDAA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| AL LYTTON | — |
| LAUREN ELIZABETH SEMENIUK | — |
Health Issues HCR
Medication affordability and access; general diabetes prevention; S 1948/HR 3709 Chronic Disease Management Act and general issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; S 2199/H.R. 4906 Insulin Price Reduction Act; H.R. 3 Elijah Cummings Lower Drug Costs Now Act; S. 1895 Lower Health Care Costs Act; H.R. 19/S 3129 Lower Costs, More Cures Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| AL LYTTON | — |
| LAUREN ELIZABETH SEMENIUK | — |
Medicare/Medicaid MMM
H.R. 1530/S. 595 Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; H.R. 1840/S. 814 Expanding Access to DSMT Act (Diabetes Self-Management Training); Medicare Diabetes Prevention Program; issues related to podiatric services; issues related to diabetic vision loss and blindness prevention; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP) diabetes self-management education; issues related to Medicare Part D; issues related to International Price Indexing (IPI)/reference pricing in Medicare; H.R. 107 related to maximum Medicaid rebates; Medicare Part D Rebate Rule; 6 Protected Classes in Medicare Part D; S.2543 Prescription Drug Pricing Reduction Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| AL LYTTON | — |
| LAUREN ELIZABETH SEMENIUK | — |
Budget/Appropriations BUD
HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; HR 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| AL LYTTON | — |
| LAUREN ELIZABETH SEMENIUK | — |
Government Issues GOV
Issues related to lobbying disclosure and political participation for US affiliates in H.R. 1 For the People Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| AL LYTTON | — |
| LAUREN ELIZABETH SEMENIUK | — |
Pharmacy PHA
H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book Transparency Act of 2019; issues related to importation; issues related to 340B; HR 4244 MAGIC (Market Access for Generic Insulin Competition) Act to provide for a pathway for chemically synthesized insulin to be approved under an abbreviated new drug application submitted under the Federal Food, Drug, and Cosmetic Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| AL LYTTON | — |
| LAUREN ELIZABETH SEMENIUK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.